Home Patent Forecast® Sectors Log In   Contact  

Pandemics/Epidemics (Free)


CureVac is a German base biopharmaceutical company that specializes in developing therapies that utilize messenger RNA. More specifically, they aim to develop mRNA-based vaccines for infectious diseases as well as drugs to treat cancer and rare diseases.

News and Insights

CUREVAC AG Owned Patent Documents in this Patent Forecast
Loading Documents...